Initially, Morales et al. established the link between EMP2 and vascular endothelial growth factors (VEGF) in ARPE-19 cells, with Gordon et al. confirming EMP2’s influence on angiogenesis in endometrial cancer through VEGF induction [28, 29]. This evidence concerns the gene VEGFA and endometrial cancer.